6.38
price down icon1.54%   -0.10
after-market Dopo l'orario di chiusura: 6.38
loading
Precedente Chiudi:
$6.48
Aprire:
$6.4
Volume 24 ore:
1.21M
Relative Volume:
0.89
Capitalizzazione di mercato:
$646.68M
Reddito:
-
Utile/perdita netta:
$-167.48M
Rapporto P/E:
-3.2718
EPS:
-1.95
Flusso di cassa netto:
$-197.47M
1 W Prestazione:
+1.75%
1M Prestazione:
-16.93%
6M Prestazione:
-54.20%
1 anno Prestazione:
-53.09%
Intervallo 1D:
Value
$6.15
$6.455
Intervallo di 1 settimana:
Value
$6.15
$6.6099
Portata 52W:
Value
$6.08
$16.76

Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile

Name
Nome
Day One Biopharmaceuticals Inc
Name
Telefono
650 484-0899
Name
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Name
Dipendente
181
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
DAWN's Discussions on Twitter

Confronta DAWN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
DAWN
Day One Biopharmaceuticals Inc
6.38 635.54M 0 -167.48M -197.47M -1.95
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-09 Reiterato Needham Buy
2024-08-01 Aggiornamento BofA Securities Underperform → Buy
2024-04-24 Reiterato Needham Buy
2023-04-25 Downgrade BofA Securities Buy → Underperform
2023-02-08 Iniziato CapitalOne Overweight
2023-02-03 Iniziato Oppenheimer Perform
2022-12-15 Iniziato H.C. Wainwright Buy
2022-12-14 Iniziato Needham Buy
2022-12-05 Iniziato Goldman Buy
2022-12-01 Iniziato BofA Securities Buy
Mostra tutto

Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie

pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 1,894 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Has $400,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 29, 2025
pulisher
May 25, 2025

36,685 Shares in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Bought by BNP Paribas Financial Markets - Defense World

May 25, 2025
pulisher
May 22, 2025

D. E. Shaw & Co. Inc. Increases Stock Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 22, 2025
pulisher
May 22, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of “Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 20, 2025

We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth - Yahoo Finance

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Grows Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 20, 2025
pulisher
May 19, 2025

Day one Biopharmaceuticals officer sells $24,574 in stock By Investing.com - Investing.com Nigeria

May 19, 2025
pulisher
May 19, 2025

Day one Biopharmaceuticals officer sells $24,574 in stock - Investing.com

May 19, 2025
pulisher
May 19, 2025

Day One Biopharmaceuticals Executives Sell Shares to Cover Tax Liabilities - TradingView

May 19, 2025
pulisher
May 15, 2025

Day one biopharmaceuticals highlights OJEMDA revenue growth and pipeline progress in Q1 2025 - MSN

May 15, 2025
pulisher
May 14, 2025

Day One Biopharmaceuticals Insider Lowered Holding By 20% During Last Year - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stake Decreased by Voya Investment Management LLC - Defense World

May 14, 2025
pulisher
May 13, 2025

Transcript : Day One Biopharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now? - MSN

May 13, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

10 Best Low Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 11, 2025

Trend Tracker for (DAWN) - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Down – Here’s What Happened - Defense World

May 11, 2025
pulisher
May 10, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 10, 2025
pulisher
May 10, 2025

Research Analysts Issue Forecasts for DAWN Q2 Earnings - Defense World

May 10, 2025
pulisher
May 10, 2025

Needham & Company LLC Cuts Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target to $27.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

Research Analysts Set Expectations for DAWN Q2 Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Analysts Issue Forecasts for DAWN Q1 Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up After Earnings Beat - Defense World

May 08, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Mariner LLC - Defense World

May 08, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 12-Month Low Following Analyst Downgrade - Defense World

May 08, 2025
pulisher
May 07, 2025

Day One Biopharma’s Earnings Call Highlights Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals (DAWN) Target Price Adjusted to $26 | DAWN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Needham Adjusts Price Target for DAWN to $27, Maintains Buy Rati - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

MetLife Investment Management LLC Raises Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals earnings beat by $0.07, revenue fell short of estimates - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals Reports Strong Q1 2025 Results - TipRanks

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 06, 2025

Day One Reports First Quarter 2025 Financial Results and Corporate Progress - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Day One Biopharmaceuticals beats Q1 2025 EPS forecast - Investing.com

May 06, 2025
pulisher
May 06, 2025

Day One Biopharmaceuticals Q1 2025 slides: OJEMDA revenue grows 11% amid market challenges - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Day One Biopharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:DAWN) - Seeking Alpha

May 06, 2025
pulisher
May 05, 2025

Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Pr - GuruFocus

May 05, 2025
pulisher
May 04, 2025

Day One Biopharmaceuticals (DAWN) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 04, 2025
pulisher
May 02, 2025

Holdings of Day One Biopharmaceuticals Inc (DAWN) are aligned with the stars - Sete News

May 02, 2025
pulisher
May 02, 2025

Wells Fargo & Company MN Sells 4,744 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 02, 2025
pulisher
May 01, 2025

Is Day One Biopharmaceuticals Inc (DAWN) worth investing in despite its overvalued state? - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

Examining the Potential Price Growth of Day One Biopharmaceuticals Inc (DAWN) - knoxdaily.com

Apr 30, 2025
pulisher
Apr 29, 2025

Market Momentum Report: Xeris Biopharma Holdings Inc (XERS)’s Positive Close at 4.41 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Azitra Inc (AZTR)’s Day in Review: Closing at 0.30, Down by -6.51 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

SuperCom Ltd (SPCB)’s Day in Review: Closing at 6.19, Down by -22.04 - DWinneX

Apr 29, 2025

Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):